S-8

     As filed with the Securities and Exchange Commission on April 17, 2003

                                                  Registration No.______________

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    Form S-8
             REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

                         Surgical Safety Products, Inc.
             (Exact name of registrant as specified in its charter)

          New York                                      65-0565144
(State or other jurisdiction of            (I.R.S. Employer Identification No.)
incorporation or organization)

          8374 Market Street
              Number 439
          Bradenton, Florida                             34202
(Address of Principal Executive Offices)              (Zip Code)

                          2003 STOCK COMPENSATION PLAN
                              (Full Title of Plan)

                                    Tim Novak
                         8374 Market Street, Number 439
                               Bradenton, FL 34202
                                 (941) 360-3039

                                 With a Copy to:

                               Lawrence E. Wilson
                           Franklin, Cardwell & Jones
                            1001 McKinney, 18th Floor
                                Houston, TX 77002
          (Name and address, including zip code, and telephone number,
             including area code, of registrant's agent for service)

                         CALCULATION OF REGISTRATION FEE
___________________________________________________________________________________________________________________

   Title of Each Class of     Amount to be    Proposed Maximum Offering       Proposed Maximum         Amount of
Securities to be Registered    Registered      Price Per Security (1)        Aggregate Offering      Registration
                                                                                 Price (1)                Fee

Common Stock, $.001 par         8,000,000               $.008                     $64,000                $5.89
value per share
___________________________________________________________________________________________________________________

In addition, pursuant to Rule 416(c) under the Securities Act of 1933, this
registration statement also covers an indeterminate amount of interests to be
offered or sold pursuant to the employee benefit plan(s) described herein.

        (1)The proposed maximum offering price per share is estimated solely for
           purpose of calculating the registration fee in accordance with Rule
           457(c) on the basis of the average of the bid and asked prices on the
           over-the-counter bulletin board market on April 15, 2003.








                                     PART I

              INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

        Pursuant to the Note to Part I of Form S-8, the Plan Information specified
by Part I is not being filed with the Securities and Exchange Commission as such
information is either contained in the 2003 Stock Compensation Plan or the stock
compensation agreement between the Registrant and each of the participants or
provided to each of the participants in accordance with Rule 428(b)(1) under the
Securities Act of 1933, as amended (the "Securities Act"). Such Stock
Compensation Plan, stock compensation agreements, additional information, and
the information incorporated by reference into this Registration Statement
pursuant to Item 3 of Part II of this Registration Statement, taken together,
constitute a prospectus that meets the requirements of Section 10(a) of the
Securities Act.


                                       I-1





                                     PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3: Incorporation of Documents by Reference.

        The Company incorporates by reference into this Registration Statement the
following documents which have been or will be filed by the Company with the
Securities and Exchange Commission (the "Commission"):

        1. Annual Report on Form 10-KSB for the fiscal year ended December 31,
2002.

        2. All other reports filed pursuant to Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), since December
31, 2002.

        3. The description of the Company's Common Stock contained in the Company's
Registration Statement on Form 10-SB, filed September 28, 1998 (Registration
Number 000-24921).

        In addition, all documents subsequently filed by the Company pursuant to
Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of
a post-effective amendment which indicates that all securities offered have been
sold or which de-registers all securities then remaining unsold, shall be deemed
to be incorporated by reference in this Registration Statement and to be a part
hereof from the date of filing of such documents.

        Any statement contained in a document incorporated by reference herein
shall be deemed to be modified or superseded for purposes of this Registration
Statement to the extent that a statement contained herein modifies or supersedes
such statement. Any such statement so modified or superseded shall not be
deemed, except as so modified or superseded, to constitute part of this
Registration Statement.

Item 4: Description of Securities.

        Not Applicable

Item 5: Interests of Named Experts and Counsel.

        Not Applicable

Item 6: Indemnification of Directors and Officers.

        Section 721 of the New York Business Corporation Law ("NYBCL") provides
that, in addition to indemnification provided in Article 7 of the NYBCL, a
corporation may indemnify a director or officer by a provision contained in the
certificate of incorporation or bylaws or by a duly authorized resolution of its
stockholders or directors or by agreement, provided that no indemnification may
be made to or on behalf of any director or officer if a judgment or other final




                                      II-1



adjudication adverse to the director or officer establishes that his acts were
committed in bad faith or were the result of active and deliberate dishonesty
and were material to the cause of action so adjudicated, or that he personally
gained in fact a financial profit or other advantage to which he was not legally
entitled.

        Section 722(a) of the NYBCL provides that a corporation may indemnify a
director or officer made, or threatened to be made, a party to any action other
than a derivative action, whether civil or criminal, against judgments, fines,
amounts paid in settlement and reasonable expenses actually and necessarily
incurred as a result of such action, if such director or officer acted, in good
faith, for a purpose which he reasonably believed to be in, or not opposed to,
the best interests of the corporation and, in criminal actions or proceedings,
in addition, had no reasonable cause to believe that his conduct was unlawful.

        Section 722(c) of the NYBCL provides that a corporation may indemnify a
director or officer, made or threatened to be made a party in a derivative
action, against amounts paid in settlement and reasonable expenses actually and
necessarily incurred by him in connection with the defense or settlement of such
action, or in connection with an appeal therein if such director or officer
acted, in good faith, for a purpose which he reasonably believed to be in, or
not opposed to, the best interests of the corporation, except that no
indemnification will be available under Section 722(c) of the NYBCL in respect
of (1) a threatened or pending action which is settled or otherwise disposed of,
or (2) any claim as to which such director or officer shall have been adjudged
liable to the corporation, unless and only to the extent that the court in which
the action was brought, or, if no action was brought, any court of competent
jurisdiction, determines upon application, that, in view of all the
circumstances of the case, the director or officer is fairly and reasonably
entitled to indemnity for such portion of the settlement amount and expenses as
the court deems proper.

        Section 723 of the NYBCL specifies the manner in which payment of
indemnification under Section 722 of the NYBCL or indemnification permitted
under Section 721 of the NYBCL may be authorized by the corporation. It provides
that indemnification by a corporation is mandatory in any case in which the
director or officer has been successful, whether on the merits or otherwise, in
defending an action. In the event that the director or officer has not been
successful or the action is settled, indemnification must be authorized by the
appropriate corporate action as set forth in Section 723.

        Section 724 of the NYBCL provides that, upon application by a director or
officer, indemnification may be awarded by a court to the extent authorized
under Section 722 and Section 723 of the NYBCL. Section 725 of the NYBCL
contains certain other miscellaneous provisions affecting the indemnification of
directors and officers.

        Section 726 of the NYBCL authorizes a corporation to purchase and maintain
insurance to indemnify (1) a corporation for any obligation which it incurs as a
result of the indemnification of directors and officers under the provisions of
Article 7 of the NYBCL, (2) directors and officers in instances in which they
may be indemnified by a corporation under the provisions of Article 7 of the
NYBCL, and (3) directors and officers in instances in which they may not



                                      II-2


otherwise be indemnified by a corporation under such section, provided the
contract of insurance covering such directors and officers provides, in a manner
acceptable to the New York State Superintendent of Insurance, for a retention
amount and for co-insurance.

        Our Certificate of Incorporation provides for exclusion of personal
liability of our directors for any breach of duty to our stockholders except in
the case of a judgment or other final adjudication adverse to such director
establishes that his or her acts or omissions were in bad faith or involved
intentional misconduct or a knowing violation of law or that he or she
personally gained in fact a financial profit or other advantage to which he or
she was not legally entitled or that his or her acts violated Section 719 of the
Business Corporation Law.

        Our bylaws provide that each of our directors and officers shall be
indemnified by the corporation against all costs and expenses actually and
necessarily incurred by them in connection with the defense of any action, suit
or proceeding in which such director or officer may be involve or to which he or
she may be made a party by reason of his or her being or having been a director
or officer of the corporation, except in relation to matters as to which he or
she shall be finally adjudged in such action, suit or proceeding to be liable
for negligence or misconduct in the performance of duty.

        The above-described provisions relating to the exclusion of liability and
indemnification of directors and officers are sufficiently broad to permit the
indemnification of such persons in certain circumstances against liabilities
arising under the Securities Act.

        Insofar as indemnification for liabilities arising under the Securities Act
may be permitted to our directors and officers, and to persons controlling our
company pursuant to the foregoing provisions, we have been informed that in the
opinion of the Securities and Exchange Commission, such indemnification is
against public policy as expressed in the Securities Act and is therefore
unenforceable.

Item 7: Exemption From Registration Claimed.

        Not Applicable

Item 8: Exhibits.

        The following exhibits are filed as part of this Registration Statement


              4.1  2003 Stock Compensation Plan.
              5.1  Opinion of Franklin, Cardwell & Jones.
             23.1  Consent of Kingery Crouse & Hohl, P.A.
             23.2  Consent of Franklin, Cardwell & Jones (included in Exhibit 5.1).
             24.1  Power of Attorney (included on Signature Page).




                                      II-3




Item 9: Undertakings.

        The undersigned registrant hereby undertakes:

        (1) To file, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement:

                (i) To include any prospectus required by Section 10(a)(3) of the
        Securities Act of 1933;

                (ii) To reflect in the prospectus any facts or events arising
        after the effective date of the registration statement (or the most
        recent post-effective amendment thereof) which, individually or in the
        aggregate, represent a fundamental change in the information set forth
        in the Registration Statement. Notwithstanding the foregoing, any
        increase or decrease in volume of securities offered (if the total
        dollar value of securities offered would not exceed that which was
        registered) and any deviation from the low or high end of the
        estimated maximum offering range may be reflected in the form of
        prospectus filed with the Commission pursuant to Rule 424(b) if, in
        the aggregate, the changes in volume and price represent no more than
        a 20% change in the maximum aggregate offering price set forth in the
        "Calculation of Registration Fee" table in the effective registration
        statement;

                (iii) To include any material information with respect to the
        plan of distribution not previously disclosed in the Registration
        Statement or any material change to such information in the
        Registration Statement;

provided, however, that paragraphs (1)(i) and (1)(ii) do not apply if the
information required to be included in a post-effective amendment by those
paragraphs is contained in periodic reports filed with or furnished to the
Commission by the registrant pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 that are incorporated by reference in the Registration
Statement.

        (2) That, for the purpose of determining any liability under the Securities
Act of 1933, each such post-effective amendment shall be deemed to be a new
registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof.

        (3) To remove from registration by means of a post-effective amendment any
of the securities being registered which remain unsold at the termination of the
offering.

        Insofar as indemnification for liabilities arising under the Securities Act
of 1933 may be permitted to directors, officers and controlling persons of the
registrant pursuant to the foregoing provisions or otherwise, the registrant has
been advised that in the opinion of the Securities and Exchange Commission such
indemnification is against public policy as expressed in the Act and is,
therefore, unenforceable. In the event that a claim for indemnification against
such liabilities (other than the payment by the registrant of expenses incurred
or paid by a director, officer or controlling person of the registrant in the




                                      II-4




successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Act and will be governed by the final adjudication of
such issue.




                                      II-5





                                   SIGNATURES

     Pursuant to the  requirements of the Securities Act of 1933, the Registrant
certifies  that it has  reasonable  grounds to believe  that it meets all of the
requirements  for  filing  on Form S-8 and has  duly  caused  this  Registration
Statement  to be  signed  on its  behalf  by  the  undersigned,  thereunto  duly
authorized, in the City of Bradenton, State of Florida, on April 15, 2003.

                                             Surgical Safety Products, Inc.


                                             BY:/s/ Tim Novak
                                                Tim Novak
                                                President and Chief Executive Officer

        Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following individuals in the
capacities and on the date indicated. Each person whose signature appears below
constitutes and appoints Tim Novak and R. Paul Gray true and lawful
attorneys-in-fact and agents, each acting alone, with full powers of
substitution and re-substitution, for him and in his name, place and stead, in
any and all capacities, to sign any and all amendments (including post-effective
amendments) to this Registration Statement, and to file the same, with all
exhibits thereto, and other documents in connection therewith, with the
Securities and Exchange Commission, granting unto said attorneys-in-fact and
agents, each acting alone, full powers and authority to do and perform each and
every act and thing requisite and necessary to be done in and about the
premises, as fully to all intents and purposes as he might or could do in
person, hereby ratifying and confirming all that said attorneys-in-fact and
agents, each acting alone, or his or her substitute or substitutes, may lawfully
do or cause to be done by virtue hereof.

        Pursuant to the requirements of the Securities Act of 1933, this April 15, 2003.

         Signature                          Title

         /s/ Tim Novak                      President and Chief Executive Officer
         Tim Novak                          (Principal Executive Officer)
                                            and Director

         /s/ R. Paul Gray                   Secretary, Treasurer and Chief Financial
         R. Paul Gray                       Officer (Principal Financial Officer
                                            and Principal Accounting Officer)
                                            and Director



                                      II-6




                                  EXHIBIT INDEX

              Exhibit  Document

                  4.1  2003 Stock Compensation Plan
                  5.1  Opinion of Franklin, Cardwell & Jones
                 23.1  Consent of Kingery Crouse & Hohl, P.A.
                 23.2  Consent of Franklin, Cardwell & Jones (included in Exhibit 5.1).
                 24.1  Power of Attorney (included on Signature Page).

EX-4

                                                                   Exhibit 4.1


                         SURGICAL SAFETY PRODUCTS, INC.

                          2003 STOCK COMPENSATION PLAN

SECTION 1. PURPOSE OF THE PLAN. The purpose of the 2003 Stock Compensation Plan
("Plan") is to maintain the ability of Surgical Safety Products, Inc., a New
York corporation (the "Company") and its subsidiaries to attract and retain
highly qualified and experienced directors, employees and consultants and to
give such directors, employees and consultants a continued proprietary interest
in the success of the Company and its subsidiaries. In addition the Plan is
intended to encourage ownership of common stock, $.001 par value ("Common
Stock"), of the Company by the directors, employees and consultants of the
Company and its Affiliates (as defined below) and to provide increased incentive
for such persons to render services and to exert maximum effort for the success
of the Company's business. The Plan provides eligible employees and consultants
the opportunity to participate in the enhancement of shareholder value by the
grants of warrants, options, restricted Common Stock, unrestricted Common Stock
and other awards under this Plan and to have their bonuses and/or consulting
fees payable in warrants, restricted Common Stock, unrestricted Common Stock and
other awards, or any combination thereof. In addition, the Company expects that
the Plan will further strengthen the identification of the directors, employees
and consultants with the stockholders. Certain options and warrants to be
granted under this Plan are intended to qualify as Incentive Stock Options
("ISOs") pursuant to Section 422 of the Internal Revenue Code of 1986, as
amended ("Code"), while other options and warrants granted under this Plan will
be nonqualified options or warrants which are not intended to qualify as ISOs
("Nonqualified Options"), either or both as provided in the agreements
evidencing the options or warrants described in Section 5. Employees,
consultants and directors who participate or become eligible to participate in
this Plan from time to time are referred to collectively herein as
"Participants". As used in this Plan, the term "Affiliates" means any "parent
corporation" of the Company and any "subsidiary corporation" of the Company
within the meaning of Code Sections 424(e) and (f), respectively.

SECTION 2. ADMINISTRATION OF THE PLAN.

(a) Committee. The Plan shall be administered by the Board of Directors of the
Company (the "Board") or a committee thereof designated by the Board with the
specific authority to administer the Plan. When acting in such capacity the
Board is herein referred to as the "Committee". If the Company is governed by
Rule 16b-3 promulgated by the Securities and Exchange Commission ("Commission")
pursuant to the Securities Exchange Act of 1934, as amended ("Exchange Act"), no
director shall serve as a member of the Committee unless he or she is a
"disinterested person" within the meaning of such Rule 16b-3.

(b) Committee Action. The Committee shall hold its meetings at such times and
places as it may determine. A majority of its members shall constitute a quorum,
and all determinations of the Committee shall be made by not less than a
majority of its members. Any decision or determination reduced to writing and



                                       1


signed by a majority of the members shall be fully as effective as if it had
been made by a majority vote of its members at a meeting duly called and held.
The Committee may designate the Secretary of the Company or other Company
employees to assist the Committee in the administration of the Plan, and may
grant authority to such persons to execute award agreements or other documents
on behalf of the Committee and the Company. Any duly constituted committee of
the Board satisfying the qualifications of this Section 2 may be appointed as
the Committee.

(c) Committee Expenses. All expenses and liabilities incurred by the Committee
in the administration of the Plan shall he borne by the Company. The Committee
may employ attorneys, consultants, accountants or other persons.

SECTION 3. STOCK RESERVED FOR THE PLAN. Subject to adjustment as provided in
Section 5(d)(xiii) hereof the aggregate number of shares that may be optioned,
subject to conversion or issued under the Plan is 8,000,000 shares of Common
Stock, warrants, options, or any combination thereof. The shares subject to the
Plan shall consist of authorized but unissued shares of Common Stock and such
number of shares shall be and is hereby reserved for sale for such purpose. Any
of such shares which may remain unsold and which are not subject to issuance
upon exercise of outstanding options or warrants at the termination of the Plan
shall cease to be reserved for the purpose of the Plan, but until termination of
the Plan or the termination of the last of the options or warrants granted under
the Plan, whichever last occurs, the Company shall at all times reserve a
sufficient number of shares to meet the requirements of the Plan. Should any
option or warrant expire or be cancelled prior to its exercise in full, the
shares theretofore subject to such option or warrant may again be made subject
to an option or warrant under the Plan.

SECTION 4. ELIGIBILITY. The Participants shall include directors, employees,
including officers, of the Company and its divisions and subsidiaries, and
consultants and attorneys who provide bona fide services to the Company.
Participants are eligible to be granted warrants, options, restricted Common
Stock, unrestricted Common Stock and other awards under this Plan and to have
their bonuses and/or consulting fees payable in warrants, restricted Common
Stock, unrestricted Common Stock and other awards. A Participant who has been
granted an option or warrant hereunder may be granted an additional option or
warrant, options or warrants, if the Committee shall so determine.

SECTION 5. GRANT OF OPTIONS OR WARRANTS.

(a) Committee Discretion. The Committee shall have sole and absolute
discretionary authority (i) to determine, authorize, and designate those persons
pursuant to this Plan who are to receive warrants, options, restricted Common
Stock, or unrestricted Common Stock under the Plan, (ii) to determine the number
of shares of Common Stock to be covered by such grant or such options or
warrants and the terms thereof, (iii) to determine the type of Common Stock
granted: restricted Common Stock, unrestricted Common Stock or a combination of
restricted and unrestricted Common Stock , and (iv) to determine the type of
option or warrant granted: ISO, Nonqualified Option or a combination of ISO and
Nonqualified Options. The Committee shall thereupon grant options or warrants in
accordance with such determinations as evidenced by a written option or warrant
agreement. Subject to the express provisions of the Plan, the Committee shall




                                       2


have discretionary authority to prescribe, amend and rescind rules and
regulations relating to the Plan, to interpret the Plan, to prescribe and amend
the terms of the option or warrant agreements (which need not be identical) and
to make all other determinations deemed necessary or advisable for the
administration of the Plan.

(b) Stockholder Approval. All ISOs granted under this Plan are subject to, and
may not be exercised before, the approval of this Plan by the stockholders prior
to the first anniversary date of the Board meeting held to approve the Plan, by
the affirmative vote of the holders of a majority of the outstanding shares of
the Company present, or represented by proxy, and entitled to vote thereat, or
by written consent in accordance with the laws of the State of New York,
provided that if such approval by the stockholders of the Company is not
forthcoming, all options or warrants and stock awards previously granted under
this Plan other than ISOs shall be valid in all respects.

(c) Limitation on Incentive Stock Options and Warrants. The aggregate fair
market value (determined in accordance with Section 5(d)(ii) of this Plan at the
time the option or warrant is granted) of the Common Stock with respect to which
ISOs may be exercisable for the first time by any Participant during any
calendar year under all such plans of the Company and its Affiliates shall not
exceed $1,000,000.

(d) Terms and Conditions. Each option or warrant granted under the Plan shall be
evidenced by an agreement, in a form approved by the Committee, which shall be
subject to the following express terms and conditions and to such other terms
and conditions as the Committee may deem appropriate:

        (i) Option or Warrant Period. The Committee shall promptly notify the
        Participant of the option or warrant grant and a written agreement
        shall promptly be executed and delivered by and on behalf of the
        Company and the Participant, provided that the option or warrant grant
        shall expire if a written agreement is not signed by said Participant
        (or his agent or attorney) and returned to the Company within 60 days
        from date of receipt by the Participant of such agreement. The date of
        grant shall be the date the option or warrant is actually granted by
        the Committee, even though the written agreement may be executed and
        delivered by the Company and the Participant after that date. Each
        option or warrant agreement shall specify the period for which the
        option or warrant thereunder is granted (which in no event shall
        exceed ten years from the date of grant) and shall provide that the
        option or warrant shall expire at the end of such period. If the
        original term of an option or warrant is less than ten years from the
        date of grant, the option or warrant may be amended prior to its
        expiration, with the approval of the Committee and the Participant, to
        extend the term so that the term as amended is not more than ten years
        from the date of grant. However, in the case of an ISO granted to an
        individual who, at the time of grant, owns stock possessing more than
        10 percent of the total combined voting power of all classes of stock
        of the Company or its Affiliate ("Ten Percent Stockholder"), such
        period shall not exceed five years from the date of grant.

        (ii) Option or Warrant Price. The purchase price of each share of
        Common Stock subject to each option or warrant granted pursuant to the
        Plan shall be determined by the Committee at the time the option or




                                       3



        warrant is granted and, in the case of ISOs, shall not be less than
        100% of the fair market value of a share of Common Stock on the date
        the option or warrant is granted, as determined by the Committee. In
        the case of an ISO granted to a Ten Percent Stockholder, the option or
        warrant price shall not be less than 110% of the fair market value of
        a share of Common Stock on the date the option or warrant is granted.
        The purchase price of each share of Common Stock subject to a
        Nonqualified Option or Warrant under this Plan shall be determined by
        the Committee prior to granting the option or warrant. The Committee
        shall set the purchase price for each share subject to a Nonqualified
        Option or Warrant at either the fair market value of each share on the
        date the option or warrant is granted, or at such other price as the
        Committee in its sole discretion shall determine.

        At the time a determination of the fair market value of a share of
        Common Stock is required to be made hereunder, the determination of
        its fair market value shall be made by the Committee in such manner as
        it deems appropriate.

        (iii) Exercise Period. The Committee may provide in the option or
        warrant agreement that an option or warrant may be exercised in whole,
        immediately, or is to be exercisable in increments. In addition, the
        Committee may provide that the exercise of all or part of an option or
        warrant is subject to specified performance by the Participant.

        (iv) Procedure for Exercise. Options or warrants shall be exercised in
        the manner specified in the option or warrant agreement. The notice of
        exercise shall specify the address to which the certificates for such
        shares are to be mailed. A Participant shall be deemed to be a
        stockholder with respect to shares covered by an option or warrant on
        the date specified in the option or warrant agreement. As promptly as
        practicable, the Company shall deliver to the Participant or other
        holder of the warrant, certificates for the number of shares with
        respect to which such option or warrant has been so exercised, issued
        in the holder's name or such other name as holder directs; provided,
        however, that such delivery shall be deemed effected for all purposes
        when a stock transfer agent of the Company shall have deposited such
        certificates with a carrier for overnight delivery, addressed to the
        holder at the address specified pursuant to this Section 6(d).

        (v) Termination of Employment. If an executive officer to whom an
        option or warrant is granted ceases to be employed by the Company for
        any reason other than death or disability, any option or warrant which
        is exercisable on the date of such termination of employment may be
        exercised during a period beginning on such date and ending at the
        time set forth in the option or warrant agreement; provided, however,
        that if a Participant's employment is terminated because of the
        Participant's theft or embezzlement from the Company, disclosure of
        trade secrets of the Company or the commission of a willful, felonious
        act while in the employment of the Company (such reasons shall
        hereinafter be collectively referred to as "for cause"), then any
        option or warrant or unexercised portion thereof granted to said
        Participant shall expire upon such termination of employment.
        Notwithstanding the foregoing, no ISO may be exercised later than
        three months after an employee's termination of employment for any
        reason other than death or disability.



                                       4



        (vi) Disability or Death of Participant. In the event of the
        determination of disability or death of a Participant under the Plan
        while he or she is employed by the Company, the options or warrants
        previously granted to him may be exercised (to the extent he or she
        would have been entitled to do so at the date of the determination of
        disability or death) at any time and from time to time, within a
        period beginning on the date of such determination of disability or
        death and ending at the time set forth in the option or warrant
        agreement, by the former employee, the guardian of his estate, the
        executor or administrator of his estate or by the person or persons to
        whom his rights under the option or warrant shall pass by will or the
        laws of descent and distribution, but in no event may the option or
        warrant be exercised after its expiration under the terms of the
        option or warrant agreement. Notwithstanding the foregoing, no ISO may
        be exercised later than one year after the determination of disability
        or death. A Participant shall be deemed to be disabled if, in the
        opinion of a physician selected by the Committee, he or she is
        incapable of performing services for the Company of the kind he or she
        was performing at the time the disability occurred by reason of any
        medically determinable physical or mental impairment which can be
        expected to result in death or to be of long, continued and indefinite
        duration. The date of determination of disability for purposes hereof
        shall be the date of such determination by such physician.

        (vii) Assignability. An option or warrant shall not be assignable or
        otherwise transferable, in whole or in part, by a Participant except
        that an option or warrant may be transferable to a member of the
        Participant's immediate family or to a trust in which the Participant
        and members of his immediate family are the only beneficiaries.

        (viii) Incentive Stock Options. Each option or warrant agreement may
        contain such terms and provisions as the Committee may determine to be
        necessary or desirable in order to qualify an option or warrant
        designated as an incentive stock option.

        (ix) Restricted Stock Awards. Awards of restricted stock under this
        Plan shall be subject to all the applicable provisions of this Plan,
        including the following terms and conditions, and to such other terms
        and conditions not inconsistent therewith, as the Committee shall
        determine:

                (A) Awards of restricted stock may be in addition to or in lieu
                of option or warrant grants. Awards may be conditioned on the
                attainment of particular performance goals based on criteria
                established by the Committee at the time of each award of
                restricted stock. During a period set forth in the agreement (the
                "Restriction Period"), the recipient shall not be permitted to
                sell, transfer, pledge, or otherwise encumber the shares of
                restricted stock; except that such shares may be used, if the
                agreement permits, to pay the option or warrant price pursuant to
                any option or warrant granted under this Plan, provided an equal
                number of shares delivered to the Participant shall carry the
                same restrictions as the shares so used. Shares of restricted
                stock shall become free of all restrictions if during the
                Restriction Period, (i) the recipient dies, (ii) the recipient's
                directorship, employment, or consultancy terminates by reason of




                                       5




                permanent disability, as determined by the Committee, (iii) the
                recipient retires after attaining both 59 1/2 years of age and
                five years of continuous service with the Company and/or a
                division or subsidiary, or (iv) if provided in the agreement,
                there is a "change in control" of the Company (as defined in such
                agreement). The Committee may require medical evidence of
                permanent disability, including medical examinations by
                physicians selected by it. Unless and to the extent otherwise
                provided in the agreement, shares of restricted stock shall be
                forfeited and revert to the Company upon the recipient's
                termination of directorship, employment or consultancy during the
                Restriction Period for any reason other than death, permanent
                disability, as determined by the Committee, retirement after
                attaining both 59 1/2 years of age and five years of continuous
                service with the Company and/or a subsidiary or division, or, to
                the extent provided in the agreement, a "change in control" of
                the Company (as defined in such agreement), except to the extent
                the Committee, in its sole discretion, finds that such forfeiture
                might not be in the best interests of the Company and, therefore,
                waives all or part of the application of this provision to the
                restricted stock held by such recipient. Certificates for
                restricted stock shall be registered in the name of the recipient
                but shall be imprinted with the appropriate legend and returned
                to the Company by the recipient, together with a stock power
                endorsed in blank by the recipient. The recipient shall be
                entitled to vote shares of restricted stock and shall be entitled
                to all dividends paid thereon, except that dividends paid in
                Common Stock or other property shall also be subject to the same
                restrictions.

                (B) Restricted Stock shall become free of the foregoing
                restrictions upon expiration of the applicable Restriction Period
                and the Company shall then deliver to the recipient Common Stock
                certificates evidencing such stock. Restricted stock and any
                Common Stock received upon the expiration of the restriction
                period shall be subject to such other transfer restrictions
                and/or legend requirements as are specified in the applicable
                agreement.

        (x) Bonuses and Past Salaries and Fees Payable in Unrestricted Stock.

                (A) In lieu of cash bonuses otherwise payable under the Company's
                or applicable division's or subsidiary's compensation practices
                to employees and consultants eligible to participate in this
                Plan, the Committee, in its sole discretion, may determine that
                such bonuses shall be payable in unrestricted Common Stock or
                partly in unrestricted Common Stock and partly in cash. Such
                bonuses shall be in consideration of services previously
                performed and as an incentive toward future services and shall
                consist of shares of unrestricted Common Stock subject to such
                terms as the Committee may determine in its sole discretion. The
                number of shares of unrestricted Common Stock payable in lieu of
                a bonus otherwise payable shall be determined by dividing such
                bonus amount by the fair market value of one share of Common
                Stock on the date the bonus is payable, with fair market value
                determined as of such date in accordance with Section 5(d)(ii).

                (B) In lieu of salaries and fees otherwise payable by the Company
                to employees, attorneys and consultants eligible to participate




                                       6



                in this Plan that were incurred for services rendered during,
                prior or after the year of 2003, the Committee, in its sole
                discretion, may determine that such unpaid salaries and fees
                shall be payable in unrestricted Common Stock or partly in
                unrestricted Common Stock and partly in cash. Such awards shall
                be in consideration of services previously performed and as an
                incentive toward future services and shall consist of shares of
                unrestricted Common Stock subject to such terms as the Committee
                may determine in its sole discretion. The number of shares of
                unrestricted Common Stock payable in lieu of salaries and fees
                otherwise payable shall be determined by dividing each calendar
                month's of unpaid salary or fee amount by the average trading
                value of the Common Stock for the calendar month during which the
                subject services were provided.

        (xi) No Rights as Stockholder. No Participant shall have any rights as
        a stockholder with respect to shares covered by an option or warrant
        until the option or warrant is exercised as provided in clause (d)
        above.

        (xii) Extraordinary Corporate Transactions. The existence of
        outstanding options or warrants shall not affect in any way the right
        or power of the Company or its stockholders to make or authorize any
        or all adjustments, recapitalizations, reorganizations, exchanges, or
        other changes in the Company's capital structure or its business, or
        any merger or consolidation of the Company, or any issuance of Common
        Stock or other securities or subscription rights thereto, or any
        issuance of bonds, debentures, preferred or prior preference stock
        ahead of or affecting the Common Stock or the rights thereof, or the
        dissolution or liquidation of the Company, or any sale or transfer of
        all or any part of its assets or business, or any other corporate act
        or proceeding, whether of a similar character or otherwise. If the
        Company recapitalizes or otherwise changes its capital structure, or
        merges, consolidates, sells all of its assets or dissolves (each of
        the foregoing a "Fundamental Change"), then thereafter upon any
        exercise of an option or warrant theretofore granted the Participant
        shall be entitled to purchase under such option or warrant, in lieu of
        the number of shares of Common Stock as to which option or warrant
        shall then be exercisable, the number and class of shares of stock and
        securities to which the Participant would have been entitled pursuant
        to the terms of the Fundamental Change if, immediately prior to such
        Fundamental Change, the Participant had been the holder of record of
        the number of shares of Common Stock as to which such option or
        warrant is then exercisable. If (i) the Company shall not be the
        surviving entity in any merger or consolidation (or survives only as a
        subsidiary of another entity), (ii) the Company sells all or
        substantially all of its assets to any other person or entity (other
        than a wholly owned subsidiary), (iii) any person or entity (including
        a "group" as contemplated by Section 13(d)(3) of the Exchange Act)
        acquires or gains ownership or control of (including, without
        limitation, power to vote) more than 50% of the outstanding shares of
        Common Stock, (iv) the Company is to be dissolved and liquidated, or
        (v) as a result of or in connection with a contested election of
        directors, the persons who were directors of the Company before such
        election shall cease to constitute a majority of the Board (each such
        event in clauses (i) through (v) above is referred to herein as a
        "Corporate Change"), the Committee, in its sole discretion, may



                                       7


        accelerate the time at which all or a portion of a Participant's
        option or warrants may be exercised for a limited period of time
        before or after a specified date.

        (xiii) Changes in Company's Capital Structure. If the outstanding
        shares of Common Stock or other securities of the Company, or both,
        for which the option or warrant is then exercisable at any time be
        changed or exchanged by declaration of a stock dividend, stock split,
        combination of shares, recapitalization, or reorganization, the number
        and kind of shares of Common Stock or other securities which are
        subject to the Plan or subject to any options or warrants theretofore
        granted, and the option or warrant prices, shall be adjusted only as
        provided in the option or warrant.

        (xiv) Acceleration of Options and Warrants. Except as hereinbefore
        expressly provided, (i) the issuance by the Company of shares of stock
        or any class of securities convertible into shares of stock of any
        class, for cash, property, labor or services, upon direct sale, upon
        the exercise of rights or warrants to subscribe therefor, or upon
        conversion of shares or obligations of the Company convertible into
        such shares or other securities, (ii) the payment of a dividend in
        property other than Common Stock or (iii) the occurrence of any
        similar transaction, and in any case whether or not for fair value,
        shall not affect, and no adjustment by reason thereof shall be made
        with respect to, the number of shares of Common Stock subject to
        options or warrants theretofore granted or the purchase price per
        share, unless the Committee shall determine, in its sole discretion,
        that an adjustment is necessary to provide equitable treatment to
        Participant. Notwithstanding anything to the contrary contained in
        this Plan, the Committee may, in its sole discretion, accelerate the
        time at which any option or warrant may be exercised, including, but
        not limited to, upon the occurrence of the events specified in this
        Section 5, and is authorized at any time (with the consent of the
        Participant) to purchase options or warrants pursuant to Section 6.

SECTION 6. RELINQUISHMENT OF OPTIONS OR WARRANTS.

(a) The Committee, in granting options or warrants hereunder, shall have
discretion to determine whether or not options or warrants shall include a right
of relinquishment as hereinafter provided by this Section 6. The Committee shall
also have discretion to determine whether an option or warrant agreement
evidencing an option or warrant initially granted by the Committee without a
right of relinquishment shall be amended or supplemented to include such a right
of relinquishment. Neither the Committee nor the Company shall be under any
obligation or incur any liability to any person by reason of the Committee's
refusal to grant or include a right of relinquishment in any option or warrant
granted hereunder or in any option or warrant agreement evidencing the same.
Subject to the Committee's determination in any case that the grant by it of a
right of relinquishment is consistent with Section 1 hereof, any option or
warrant granted under this Plan, and the option or warrant agreement evidencing
such option or warrant, may provide:

        (i) That the Participant, or his or her heirs or other legal
        representatives to the extent entitled to exercise the option or
        warrant under the terms thereof, in lieu of purchasing the entire
        number of shares subject to purchase thereunder, shall have the right
        to relinquish all or any part of the then unexercised portion of the
        option or warrant (to the extent then exercisable) for a number of



                                       8



        shares of Common Stock to be determined in accordance with the
        following provisions of this clause (i):

                (A) The written notice of exercise of such right of
                relinquishment shall state the percentage of the total number of
                shares of Common Stock issuable pursuant to such relinquishment
                (as defined below) that the Participant elects to receive;

                (B) The number of shares of Common Stock, if any, issuable
                pursuant to such relinquishment shall be the number of such
                shares, rounded to the next greater number of full shares, as
                shall be equal to the quotient obtained by dividing (i) the
                Appreciated Value by (ii) the purchase price for each of such
                shares specified in such option or warrant;

                (C) For the purpose of this clause (C), "Appreciated Value" means
                the excess, if any, of (x) the total current market value of the
                shares of Common Stock covered by the option or warrant or the
                portion thereof to be relinquished over (y) the total purchase
                price for such shares specified in such option or warrant;

        (ii) That such right of relinquishment may be exercised only upon
        receipt by the Company of a written notice of such relinquishment
        which shall be dated the date of election to make such relinquishment;
        and that, for the purposes of this Plan, such date of election shall
        be deemed to be the date when such notice is sent by registered or
        certified mail, or when receipt is acknowledged by the Company, if
        mailed by other than registered or certified mail or if delivered by
        hand or by any telegraphic communications equipment of the sender or
        otherwise delivered; provided, that, in the event the method just
        described for determining such date of election shall not be or remain
        consistent with the provisions of Section 16(b) of the Exchange Act or
        the rules and regulations adopted by the Commission thereunder, as
        presently existing or as may be hereafter amended, which regulations
        exempt from the operation of Section 16(b) of the Exchange Act in
        whole or in part any such relinquishment transaction, then such date
        of election shall be determined by such other method consistent with
        Section 16(b) of the Exchange Act or the rules and regulations
        thereunder as the Committee shall in its discretion select and apply;

        (iii) That the "current market value" of a share of Common Stock on a
        particular date shall be deemed to be its fair market value on that
        date as determined in accordance with Paragraph 5(d)(ii); and

        (iv) That the option or warrant, or any portion thereof, may be
        relinquished only to the extent that (A) it is exercisable on the date
        written notice of relinquishment is received by the Company, and (B)
        the holder of such option or warrant pays, or makes provision
        satisfactory to the Company for the payment of, any taxes which the
        Company is obligated to collect with respect to such relinquishment.

(b) The Committee shall have sole discretion to consent to or disapprove, and
neither the Committee nor the Company shall be under any liability by reason of
the Committee's disapproval of, any election by a holder of options or warrants




                                       9




to relinquish such options or warrants in whole or in part as provided in
Paragraph 6(a), except that no such consent to or approval of a relinquishment
shall be required under the following circumstances. Each Participant who is
subject to the short-swing profits recapture provisions of Section 16(b) of the
Exchange Act ("Covered Participant") shall not be entitled to receive shares of
Common Stock when options or warrants are relinquished during any window period
commencing on the third business day following the Company's release of a
quarterly or annual summary statement of sales and earnings and ending on the
twelfth business day following such release ("Window Period"). A Covered
Participant shall be entitled to receive shares of Common Stock upon the
relinquishment of options or warrants outside a Window Period.

(c) The Committee, in granting options or warrants hereunder, shall have
discretion to determine the terms upon which such options or warrants shall be
relinquishable, subject to the applicable provisions of this Plan, and including
such provisions as are deemed advisable to permit the exemption from the
operation from Section 16(b) of the Exchange Act of any such relinquishment
transaction, and options or warrants outstanding, and option agreements
evidencing such options, may be amended, if necessary, to permit such exemption.
If options or warrants are relinquished, such option or warrant shall be deemed
to have been exercised to the extent of the number of shares of Common Stock
covered by the option or warrant or part thereof which is relinquished, and no
further options or warrants may be granted covering such shares of Common Stock.

(d) Any options or warrants or any right to relinquish the same to the Company
as contemplated by this Paragraph 6 shall be assignable by the Participant,
provided the transaction complies with any applicable securities laws.

(e) Except as provided in Section 6(f) below, no right of relinquishment may be
exercised within the first six months after the initial award of any option or
warrant containing, or the amendment or supplementation of any existing option
or warrant agreement adding, the right of relinquishment.

(f) No right of relinquishment may be exercised after the initial award of any
option or warrant containing, or the amendment or supplementation of any
existing option or warrant agreement adding the right of relinquishment, unless
such right of relinquishment is effective upon the Participant's death,
disability or termination of his relationship with the Company for a reason
other than "for cause."

SECTION 7. AMENDMENTS OR TERMINATION. The Board may amend, alter or discontinue
the Plan, but no amendment or alteration shall be made which would impair the
rights of any Participant, without his consent, under any option or warrant
theretofore granted.

SECTION 8. COMPLIANCE WITH OTHER LAWS AND REGULATIONS. The Plan, the grant and
exercise of options or warrants thereunder, and the obligation of the Company to
sell and deliver shares under such options or warrants, shall be subject to all
applicable federal and state laws, rules and regulations and to such approvals
by any governmental or regulatory agency as may be required. The Company shall
not be required to issue or deliver any certificates for shares of Common Stock




                                       10



prior to the completion of any registration or qualification of such shares
under any federal or state law or issuance of any ruling or regulation of any
government body which the Company shall, in its sole discretion, determine to be
necessary or advisable. Any adjustments provided for in subparagraphs 5(d)(xii),
(xiii) and (xiv) shall be subject to any shareholder action required by the
corporate law of the state of incorporation of the Company.

SECTION 9. PURCHASE FOR INVESTMENT. Unless the options, warrants, and shares of
Common Stock covered by this Plan have been registered under the Securities Act
of 1933, as amended, or the Company has determined that such registration is
unnecessary, each person acquiring or exercising an option or warrant under this
Plan may be required by the Company to give a representation in writing that he
or she is acquiring such option or warrant or such shares for his own account
for investment and not with a view to, or for sale in connection with, the
distribution of any part thereof.

SECTION 10. TAXES.

(a) The Company may make such provisions as it may deem appropriate for the
withholding of any taxes which it determines is required in connection with any
options or warrants granted under this Plan.

(b) Notwithstanding the terms of Paragraph 10(a), any Participant may pay all or
any portion of the taxes required to be withheld by the Company or paid by him
or her in connection with the exercise of a nonqualified option or warrant by
electing to have the Company withhold shares of Common Stock, or by delivering
previously owned shares of Common Stock, having a fair market value, determined
in accordance with Paragraph 5(d)(ii), equal to the amount required to be
withheld or paid. A Participant must make the foregoing election on or before
the date that the amount of tax to be withheld is determined ("Tax Date"). All
such elections are irrevocable and subject to disapproval by the Committee.
Elections by Covered Participants are subject to the following additional
restrictions: (i) such election may not be made within six months of the grant
of an option or warrant, provided that this limitation shall not apply in the
event of death or disability, and (ii) such election must be made either six
months or more prior to the Tax Date or in a Window Period. Where the Tax Date
in respect of an option or warrant is deferred until six months after exercise
and the Covered Participant elects share withholding, the full amount of shares
of Common Stock will be issued or transferred to him upon exercise of the option
or warrant, but he or she shall be unconditionally obligated to tender back to
the Company the number of shares necessary to discharge the Company's
withholding obligation or his estimated tax obligation on the Tax Date.

SECTION 11. REPLACEMENT OF OPTIONS AND WARRANTS. The Committee from time to time
may permit a Participant under the Plan to surrender for cancellation any
unexercised outstanding option or warrant and receive from the Company in
exchange an option or warrant for such number of shares of Common Stock as may
be designated by the Committee. The Committee may, with the consent of the
holder of any outstanding option or warrant, amend such option or warrant,
including reducing the exercise price of any option or warrant to not less than
the fair market value of the Common Stock at the time of the amendment and
extending the exercise term of any warrant or option.



                                       12



SECTION 12. NO RIGHT TO COMPANY EMPLOYMENT. Nothing in this Plan or as a result
of any option or warrant granted pursuant to this Plan shall confer on any
individual any right to continue in the employ of the Company or interfere in
any way with the right of the Company to terminate an individual's employment at
any time. The option or warrant agreements may contain such provisions as the
Committee may approve with reference to the effect of approved leaves of
absence.

SECTION 13. LIABILITY OF COMPANY. The Company and any Affiliate which is in
existence or hereafter comes into existence shall not be liable to a Participant
or other persons as to:

(a) The Non-Issuance of Shares. The non-issuance or sale of shares as to which
the Company has been unable to obtain from any regulatory body having
jurisdiction the authority deemed by the Company's counsel to be necessary to
the lawful issuance and sale of any shares hereunder; and

(b) Tax Consequences. Any tax consequence expected, but not realized, by any
Participant or other person due to the exercise of any option or warrant granted
hereunder.

SECTION 14. EFFECTIVENESS AND EXPIRATION OF PLAN. The Plan shall be effective on
the date the Board adopts the Plan. The Plan shall expire ten years after the
date the Board approves the Plan and thereafter no option or warrant shall be
granted pursuant to the Plan.

SECTION 15. NON-EXCLUSIVITY OF THE PLAN. Neither the adoption by the Board nor
the submission of the Plan to the stockholders of the Company for approval shall
be construed as creating any limitations on the power of the Board to adopt such
other incentive arrangements as it may deem desirable, including without
limitation, the granting of restricted stock or stock options or warrants
otherwise than under the Plan, and such arrangements may be either generally
applicable or applicable only in specific cases.

SECTION 16. GOVERNING LAW. This Plan and any agreements hereunder shall be
interpreted and construed in accordance with the laws of the state of
incorporation of the Company and applicable federal law.

SECTION 17. CASHLESS EXERCISE. The Committee also may allow cashless exercises
as permitted under Federal Reserve Board's Regulation T, subject to applicable
securities law restrictions, or by any other means which the Committee
determines to be consistent with the Plan's purpose and applicable law. The
proceeds from such a payment shall be added to the general funds of the Company
and shall be used for general corporate purposes.

EX-5

                                                         1001 MCKINNEY
                                                         18th FLOOR
                                                         HOUSTON, TEXAS 77002
FRANKLIN, CARDWELL & JONES                               713.222.6025  TELEPHONE
A PROFESSIONAL CORPORATION                               713.222.0938  FACSIMILE

                                                         INTERNET:
                                                         http://www.fcj.com


                                                                   Exhibit 5.1


April 15, 2003


Surgical Safety Products, Inc.
8374 Market Street
Number 439
Bradenton, FL 34202


Gentlemen:

We have acted as counsel to Surgical Safety Products, Inc. (the "Company"), a
New York corporation, and have participated in the preparation and adoption of
the 2003 Stock Compensation Plan (the "Plan") and the preparation of a
Registration Statement on Form S-8 (the "Registration Statement") with respect
to 8,000,000 shares (the "Shares") of Common Stock, $.001 par value, of the
Company to be offered to directors, officers, employees and consultants of the
Company pursuant to the Plan.

It is our opinion that the Shares have been duly authorized and that, when
issued either pursuant to a grant, stock award, or upon the exercise of an
option or the conversion of a warrant granted pursuant to the Plan, the Shares
will be validly issued, fully paid and nonassessable.

We hereby consent to the incorporation by reference in this Registration
Statement on Form S-8 of our opinion regarding the legality of 8,000,000 shares
of Surgical Safety Products, Inc. Common Stock, $.001 par value, to be issued
upon grants, stock awards, or exercise of options or conversion of warrants
granted pursuant to the 2003 Stock Compensation Plan.

/s/ Franklin, Cardwell & Jones

FRANKLIN, CARDWELL & JONES

EX-23

                                                                  Exhibit 23.1


                    CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS


Surgical Safety Products, Inc.
8374 Market Street
Number 439
Bradenton, FL 34202


Gentlemen:

As independent public accountants, we hereby consent to the incorporation by
reference in this Registration Statement on Form S-8 of our report dated April
15, 2003 included in the Annual Report on Form 10-KSB of Surgical Safety
Products, Inc. for the year ended December 31, 2002 and to all references to our
Firm included in this Registration Statement.

/s/ Kingery Crouse & Hohl, P.A.

Kingery Crouse & Hohl, P.A.

April 18, 2003